Neonatal Drug Therapy Manual

EPINEPHrine Inhalation Solution

Disclaimer: Official controlled document is the CHEO and Ottawa Hospital online copy. It is the responsibility of user to ensure that any paper copy version is the same as the online version before use.

Updated April 22, 2022 - 2:02pm

Classification: 
Bronchodilator, Sympathomimetic
Original Date: 
April 2022
Indications: 
  • Treatment of upper airway obstruction
Administration: 
  • Nebulization: nebulize undiluted over 10-15 minutes
Dosage: 

Epinephrine 1 mg/mL Inhalation Solution:

  • 3 mL for patients under 10 kg, 5 mL for patients greater than or equal to 10 kg.
  • May repeat dose if needed.
Side Effects: 
  • CVS: hypertension, tachycardia, vasoconstriction
Parameters to Monitor: 
  • BP, HR
Reconstitution and Stability: 
  • Protect from light.  Store at room temperature.
Compatibility: 
  • N/A
Notes: 
  • Do not use product if it is brown in color or cloudy 
  • Do not use product if it is pinkish or darker than slightly yellow, or if it contains a precipitate
References: 
  • Lexi-Comp Oline Database, accessed 2022

The information contained on this website is provided for informational purposes only, as a guide to assist physicians, nurses and other healthcare providers in deciding on the appropriate care required for a particular patient. At all times, physicians, nurses and other healthcare providers must exercise their independent clinical judgment, based on their knowledge, training and experience, taking into account the specific facts and circumstances of each patient, when deciding on the appropriate course of investigation and/or treatment to recommend in a particular clinical situation.

CHEO has made every effort to ensure that the information contained on this website is as current and accurate as possible. However, changes can occur due to ongoing research and the constant influx of new information. Where possible, hospitals and healthcare practitioners should verify the information before acting on it.

Reliance on any information in this website is at the user's own risk. CHEO is not responsible or liable for any harm, loss or other consequences from the use or misuse of the information on this website.